Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00542.2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Sarah L Speck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, St. Louis, Missouri, United States. Hauptthemen laut MEDLINE: Thiolester Hydrolases, Lipoylation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
More than half of the global population is obese or overweight, especially in Western countries, and this excess adiposity disrupts normal physiology to cause chronic diseases. Diabetes, an adiposity-associated epidemic disease, affects >500 million people, and cases are projected to exceed 1 billion before 2050. Lipid excess can impact physiology through the posttranslational modification of proteins, including the reversible process of S-palmitoylation. Dynamic palmitoylation cycling requires the S-acylation of proteins by acyltransferases and the depalmitoylation of these proteins mediated in part by acyl-protein thioesterases (APTs) such as APT1. Emerging evidence points to tissue-specific roles for the depalmitoylase APT1 in maintaining homeostasis in the vasculature, pancreatic islets, and liver. These recent findings raise the possibility that APT1 substrates can be therapeutically targeted to treat the complications of metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, St. Louis, Missouri, United States.
ORCID-Profile: Clay F Semenkovich
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- HHS | NIH | National Institute of General Medical Sciences
- HHS | NIH | National Institute on Aging
- Washington University in St. Louis
Zitieren
APA
Speck, S. L., Wei, X., & Semenkovich, C. F. (2024). Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00542.2023
Vancouver
Speck SL, Wei X, Semenkovich CF. Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00542.2023
BibTeX
@article{Speck2024,
author = {Speck, Sarah L and Wei, Xiaochao and Semenkovich, Clay F},
title = {Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00542.2023}
}
EUVIMED